In melanoma, mutations in BRAF have been found to accompany JAK3 mutations [269], while in breast cancer, mutations in such as TP53 and NOTCH1, as well as MYC amplification, have been identified alongside JAK1 mutations [270]. This evidence concerns the gene JAK1 and breast cancer.